PharmaCyte Biotech (PMCB) Return on Equity [ROE] (2013 - 2026)
PharmaCyte Biotech's Return on Equity [ROE] came in at -20.82% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 14.81 percentage points from -6.01% a year earlier and down 3.68 percentage points from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Return on Equity [ROE] was -14.37%, down 6.92 percentage points from FY2025.
- Return on Equity [ROE] carries a five-year change of +47.25 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Equity [ROE] was -7.45% in FY2025 (+2.76 pp), -10.21% in FY2024 (-4.65 pp), -5.56% in FY2023 (+3.21 pp) and -8.77% in FY2022 (+52.86 pp).
- The fiscal Q1 2027 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q1 2022.
- Year-over-year, Return on Equity [ROE] has declined for three consecutive quarters, with an average year-over-year change of -1.64 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q1 2023 (a gain of 55.41 percentage points), and the weakest in fiscal Q1 2027 (a drop of 14.81 percentage points).
- Business Quant data shows PMCB's Return on Equity [ROE] at -17.14% (Q4 2026), -12.27% (Q3 2026) and -8.42% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | PharmaCyte Biotech | 3.79 Mn | -69.05 Mn | - | -20.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -20.82% |
| Apr 30, 2026 | -17.14% |
| Jan 31, 2026 | -12.27% |
| Oct 31, 2025 | -8.42% |
| Jul 31, 2025 | -6.01% |
| Apr 30, 2025 | -6.43% |
| Jan 31, 2025 | -10.92% |
| Oct 31, 2024 | -10.64% |
| Jul 31, 2024 | -12.32% |
| Apr 30, 2024 | -17.35% |
| Jan 31, 2024 | -8.46% |
| Oct 31, 2023 | -7.40% |
| Jul 31, 2023 | -7.47% |
| Apr 30, 2023 | -6.03% |
| Jan 31, 2023 | -7.28% |
| Oct 31, 2022 | -6.76% |
| Jul 31, 2022 | -5.39% |
| Apr 30, 2022 | -4.67% |
| Jan 31, 2022 | -4.20% |
| Oct 31, 2021 | -7.76% |
API Access
PharmaCyte Biotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();